| Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential E Monzani, F Facchetti, E Galmozzi, E Corsini, A Benetti, C Cavazzin, ... European journal of cancer 43 (5), 935-946, 2007 | 735 | 2007 |
| Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ... Hepatology 51 (4), 1209-1217, 2010 | 722 | 2010 |
| HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ... Gastroenterology 138 (3), 905-912, 2010 | 345 | 2010 |
| Role of HER receptors family in development and differentiation P Casalini, MV Iorio, E Galmozzi, S Ménard Journal of cellular physiology 200 (3), 343-350, 2004 | 341 | 2004 |
| I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ... Hepatology 52 (4), 1274-1280, 2010 | 330 | 2010 |
| Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ... Hepatology 53 (3), 791-799, 2011 | 305 | 2011 |
| Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B F Lebossé, B Testoni, J Fresquet, F Facchetti, E Galmozzi, M Fournier, ... Journal of hepatology 66 (5), 897-909, 2017 | 168 | 2017 |
| Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 S De Nicola, A Aghemo, M Grazia Rumi, E Galmozzi, L Valenti, ... Hepatology 55 (2), 336-342, 2012 | 108 | 2012 |
| Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease L Valenti, E Canavesi, E Galmozzi, P Dongiovanni, R Rametta, ... Journal of hepatology 53 (5), 927-933, 2010 | 72 | 2010 |
| Cancer stem cells and therapeutic perspectives E Galmozzi, F Facchetti, CAM Porta Current medicinal chemistry 13 (6), 603-607, 2006 | 69 | 2006 |
| Hepatic fat—genetic risk score predicts hepatocellular carcinoma in patients with cirrhotic HCV treated with DAAs E Degasperi, E Galmozzi, S Pelusi, R D’Ambrosio, R Soffredini, M Borghi, ... Hepatology 72 (6), 1912-1923, 2020 | 68 | 2020 |
| Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, A Al Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ... JOURNAL OF HEPATOLOGY 52 (S1), S57-S57, 2010 | 65 | 2010 |
| Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids S Arpicco, S Canevari, M Ceruti, E Galmozzi, F Rocco, L Cattel Il Farmaco 59 (11), 869-878, 2004 | 63 | 2004 |
| Hepatitis delta virus and hepatocellular carcinoma: an update R Romeo, A Petruzziello, EI Pecheur, F Facchetti, R Perbellini, ... Epidemiology & Infection 146 (13), 1612-1618, 2018 | 58 | 2018 |
| Systematic review with meta‐analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon‐therapy in hepatitis B infection? E Galmozzi, M Vigano, P Lampertico Alimentary pharmacology & therapeutics 39 (6), 569-578, 2014 | 51 | 2014 |
| Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy PJ Clark, A Aghemo, E Degasperi, E Galmozzi, TJ Urban, DM Vock, ... Journal of viral hepatitis 20 (12), 858-866, 2013 | 46 | 2013 |
| Expression of Concern: HER2 signaling enhances 5′ UTR‐mediated translation of c‐Myc mRNA E Galmozzi, P Casalini, MV Iorio, B Casati, C Olgiati, S Ménard Journal of cellular physiology 200 (1), 82-88, 2004 | 44 | 2004 |
| p53-dependent downregulation of metastasis-associated laminin receptor M Modugno, E Tagliabue, E Ardini, V Berno, E Galmozzi, M De Bortoli, ... Oncogene 21 (49), 7478-7487, 2002 | 39 | 2002 |
| The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human α-folate receptor gene in ovarian carcinoma A Tomassetti, F Mangiarotti, M Mazzi, S Sforzini, S Miotti, E Galmozzi, ... Cancer research 63 (3), 696-704, 2003 | 35 | 2003 |
| The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent R D’Ambrosio, A Aghemo, R De Francesco, MG Rumi, E Galmozzi, ... International journal of molecular sciences 15 (5), 7213-7224, 2014 | 34 | 2014 |
